Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis
This recent original paper presents data on a potential new treatment for WD, which may address some unmet needs associated with currently available therapies
Ethics declarations Conflict of Interest Anastasiia Badaeva, Anastasiia Kosareva, Mariia Lepshina, Yulia Vorobyeva, Viacheslav Novikov declare that they have no conflicts of interest
This typically includes silicone sheets or gel, specific massage techniques to break up scar tissue, and strict sun protection
Consequently, researchers observe a significantly extended half-life (estimated between 20 to 30 hours) and substantially increased biological potency in vitro
Positive indicators include consistent reports of good results, responsive communication from clinic staff, professional and clean facilities, transparent pricing without surprises, and helpful protocol adjustments when needed